Karyopharm Therapeutics Inc (KPTI)
1.065
-0.02
(-2.29%)
USD |
NASDAQ |
Apr 25, 16:00
1.065
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Total Liabilities (Quarterly): 376.64M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 376.64M |
September 30, 2023 | 370.36M |
June 30, 2023 | 369.08M |
March 31, 2023 | 370.97M |
December 31, 2022 | 374.83M |
September 30, 2022 | 371.52M |
June 30, 2022 | 372.82M |
March 31, 2022 | 377.11M |
December 31, 2021 | 384.98M |
September 30, 2021 | 380.07M |
June 30, 2021 | 369.70M |
March 31, 2021 | 314.55M |
December 31, 2020 | 262.50M |
September 30, 2020 | 253.82M |
June 30, 2020 | 250.21M |
March 31, 2020 | 249.99M |
December 31, 2019 | 245.19M |
September 30, 2019 | 237.88M |
June 30, 2019 | 155.63M |
March 31, 2019 | 165.93M |
December 31, 2018 | 158.02M |
September 30, 2018 | 48.91M |
Date | Value |
---|---|
June 30, 2018 | 43.12M |
March 31, 2018 | 50.84M |
December 31, 2017 | 50.83M |
September 30, 2017 | 22.60M |
June 30, 2017 | 19.04M |
March 31, 2017 | 17.07M |
December 31, 2016 | 18.14M |
September 30, 2016 | 16.69M |
June 30, 2016 | 17.33M |
March 31, 2016 | 15.10M |
December 31, 2015 | 17.08M |
September 30, 2015 | 16.38M |
June 30, 2015 | 15.97M |
March 31, 2015 | 16.52M |
December 31, 2014 | 13.54M |
September 30, 2014 | 7.351M |
June 30, 2014 | 5.999M |
March 31, 2014 | 5.185M |
December 31, 2013 | 3.292M |
September 30, 2013 | 103.69M |
June 30, 2013 | 2.541M |
December 31, 2012 | 29.19M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
155.63M
Minimum
Jun 2019
384.98M
Maximum
Dec 2021
320.41M
Average
369.70M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
Geron Corp | 146.13M |
Arbutus Biopharma Corp | 38.38M |
Verastem Inc | 92.34M |
Actinium Pharmaceuticals Inc | 45.07M |
Chimerix Inc | 19.74M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 240.44M |
Shareholders Equity (Quarterly) | -136.21M |
Debt to Equity Ratio | -1.255 |
Current Ratio | 3.367 |
Net Debt Paydown Yield | -0.21% |